Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads

被引:11
|
作者
Schumacher, Frank A. [1 ]
Helenowski, Irene B. [1 ]
Oswald, Laura B. [2 ]
Gonzalez, Brian D. [2 ]
Benning, James T. [1 ]
Morgans, Alicia K. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, 1835 W Thomas St,Apt 2F, Chicago, IL 60622 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Program Hlth Outcomes & Behav, Tampa, FL USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2022年 / 16卷
关键词
prostate cancer; decision making; shared decision making; treatment decisions; cancer; INVOLVEMENT; PREFERENCES; INFORMATION; ROLES; WOMEN;
D O I
10.2147/PPA.S334827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple treatments for metastatic prostate cancer have similar efficacy, leaving patients with complicated treatment choices. Shared decision-making can facilitate difficult treatment decisions, but the extent to which this is used for metastatic prostate cancer is unknown. We assessed patient, caregiver, and physician perceptions of decision locus of control (shared decision-making vs physician- or patient-directed decisions) and the degree of agreement between groups. Methods: Triads of patients, caregivers, and physicians completed surveys of decisionmaking practices after a clinic visit in which a decision occurred. To evaluate the degree of agreement for decision locus of control, we used the quadratic-weighted kappa coefficient (Kappa). We used relative frequencies to evaluate which knowledge learned and treatment factors were most strongly endorsed by patients as informing and influencing their treatment decision-making, respectively. Results: Fifty triads participated, with median patient age of 72 years. A majority of patients, caregivers, and physicians reported shared decision-making (66%, 56%, and 52%, respectively). Patients and physicians demonstrated minimal agreement about decision locus of control (44%, Kappa=0.35 [SD = 0.52]), but caregiver reports were not statistically significantly associated with physician and patient reports (38%, Kappa=0.23, [SD = 0.28]), p=0.055; 44%, Kappa=0.34 [SD = 1.98], p=0.14). Treatment efficacy was the most common patientreported factor influencing treatment decisions (44%). Conclusion: This study characterized metastatic prostate cancer patients', caregivers', and physicians' experiences and communication preferences for treatment decision-making. Patients and physicians had greater agreement in decision locus of control compared with caregivers, yet patient-physician agreement was minimal. Metastatic prostate cancer patients report being influenced by information about treatment efficacy and clear next steps, and a desire for patient-friendly language and an invitation to be as involved in decision making at their preferred level. Emphasizing these may increase agreement in decision locus of control between all participants in the decision-making process.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [1] Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction
    Schumacher, Frank A. A.
    Helenowski, Irene B. B.
    Sun, Zequn
    Oswald, Laura B. B.
    Gonzalez, Brian D. D.
    Moses, Kelvin A. A.
    Benning, James T. T.
    Morgans, Alicia K. K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 201 - 206
  • [2] Patient participation in treatment decision-making of prostate cancer: a qualitative study
    Pan, Shucheng
    Mao, Jinjiao
    Wang, Lijuan
    Dai, Yun
    Wang, Wei
    SUPPORTIVE CARE IN CANCER, 2022, 30 (05) : 4189 - 4200
  • [3] Perceptions of Urologists About the Conversational Elements Leading to Treatment Decision-Making Among Newly Diagnosed Prostate Cancer Patients
    Adsul, Prajakta
    Wray, Ricardo
    Boyd, Danielle
    Weaver, Nancy
    Siddiqui, Sameer
    JOURNAL OF CANCER EDUCATION, 2017, 32 (03) : 580 - 588
  • [4] African American prostate cancer survivors' treatment decision-making and quality of life
    Palmer, Nynikka R. A.
    Tooze, Janet A.
    Turner, Aubrey R.
    Xu, Jianfeng
    Avis, Nancy E.
    PATIENT EDUCATION AND COUNSELING, 2013, 90 (01) : 61 - 68
  • [5] Shared decision-making - Rhetoric and reality: Women's experiences and perceptions of adjuvant treatment decision-making for breast cancer
    Mahmoodi, Neda
    Sargeant, Sally
    JOURNAL OF HEALTH PSYCHOLOGY, 2019, 24 (08) : 1082 - 1092
  • [6] Treatment decision-making among breast cancer patients in Malaysia
    Nies, Yong Hui
    Islahudin, Farida
    Chong, Wei Wen
    Abdullah, Norlia
    Ismail, Fuad
    Bustamam, Ros Suzanna Ahmad
    Wong, Yoke Fui
    Saladina, J. J.
    Shah, Noraida Mohamed
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1767 - 1777
  • [7] Patient participation in treatment decision-making of prostate cancer: a qualitative study
    Shucheng Pan
    Jinjiao Mao
    Lijuan Wang
    Yun Dai
    Wei Wang
    Supportive Care in Cancer, 2022, 30 : 4189 - 4200
  • [8] Exploring Decision-Making and Patient Treatment Preferences and Concerns in Metastatic Breast Cancer: Findings from Medical Encounters in a Randomized Control Trial
    Hendrix, Emma K.
    Henderson, Nicole L.
    Bourne, Garrett A.
    Williams, Courtney P.
    Ingram, Stacey A.
    Rocque, Gabrielle B.
    JOURNAL OF PALLIATIVE MEDICINE, 2025,
  • [9] What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists
    Rocque, Gabrielle B.
    Rasool, Aysha
    Williams, Beverly R.
    Wallace, Audrey S.
    Niranjan, Soumya J.
    Halilova, Karina I.
    Turkman, Yasemin E.
    Ingram, Stacey A.
    Williams, Courtney P.
    Forero-Torres, Andres
    Smith, Tom
    Bhatia, Smita
    Knight, Sara J.
    ONCOLOGIST, 2019, 24 (10) : 1313 - 1321
  • [10] Assessing the association between quantity and quality of family caregiver participation in decision-making clinical encounters on patient activation in the metastatic breast cancer setting
    Henderson, Nicole L.
    Padalkar, Tanvi
    Bourne, Garrett
    Hendrix, Emma K.
    Williams, Courtney P.
    Odom, J. Nicholas
    Triebel, Kristen
    Rocque, Gabrielle B.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (07)